The round was co-led by Redalpine Venture Capital and First Star Venture Capital with participation from Pikas d.o.o. and other angel investors.
The company intends to use the funds to accelerate the team’s expansion in the U.S. and commercialization of its platform.
Led by Nejc Škoberne, CEO, Genialis provides SaaS-based biological visual analytics software and an application for variant discovery by targeted genome sequencing. The system aims to learn how users prefer to interact with their data, and to optimize the analysis and user experience based on user-generated content and the opus of data in the public sphere. Early access users on the Expressions and variant discovery apps include researchers from Harvard University, CPMCRI, Johns Hopkins and Jackson Labs.
The company is based in Houston, Texas, Cambridge, Massachusetts, and Ljubljana, Slovenia.
FinSMEs
14/11/2017